Perception of Female Hormonal Contraception by the Main Prescribers

Completed

• Conditions: Female Hormonal Contraception

• Registration Number: NCT05528731
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

The recommendations for contraception, after researching contraindications to certain methods, are to offer clear and honest information to allow the patient to make an informed choice, adapted to her lifestyle. The best contraception is the one chosen by the patient. The choice of contraception illustrates the difficulty of assessing the benefit-risk balance in the context of functional and preventive treatment.

Taking into account this imbalance between patient beliefs and medical advice is an essential step in improving the provision of gynecological care.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-31
• Study First Submitted: 2022-09-02
• Study First Submitted QC: 2022-09-02
• Study First Posted: 2022-09-06
• Primary Completion: 2022-09-30
• Study Completion: 2023-01-31
• Status Verified: 2023-12
• Last Update Submitted: 2023-12-12
• Last Update Posted: 2023-12-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 385

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Study of the perception of risks and management of adverse effects of hormonal contraception among prescribers	5 months after interviews with prescribers

Trial Locations

Locations (1)

Service d'Assistance Médicale à la Procréation - CHU de Strasbourg - France; 🇫🇷 Strasbourg, France